Cite
HARVARD Citation
Papadatos-Pastos, D. et al. (2022). Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors. Journal for immunotherapy of cancer. 10 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Papadatos-Pastos, D. et al. (2022). Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors. Journal for immunotherapy of cancer. 10 (6), p. . [Online].